Targeting angiogenesis for liver cancer: Past, present, and future

Article Properties
Cite
Zhu, Xiao-Dong, et al. “Targeting Angiogenesis for Liver Cancer: Past, Present, and Future”. Genes &Amp; Diseases, vol. 7, no. 3, 2020, pp. 328-35, https://doi.org/10.1016/j.gendis.2020.03.010.
Zhu, X.-D., Tang, Z.-Y., & Sun, H.-C. (2020). Targeting angiogenesis for liver cancer: Past, present, and future. Genes &Amp; Diseases, 7(3), 328-335. https://doi.org/10.1016/j.gendis.2020.03.010
Zhu XD, Tang ZY, Sun HC. Targeting angiogenesis for liver cancer: Past, present, and future. Genes & Diseases. 2020;7(3):328-35.
Refrences
Title Journal Journal Categories Citations Publication Date
Phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC) 2020
A phase Ib study of lenvatinib (LEN) plus nivolumab (NIV) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): study 117 2020
Nivolumab (NIVO) + ipilimumab (IPI) + cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): results from CheckMate 040 2020
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 2019
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma New England Journal of Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2019
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)32
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens25
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology10
Science: Biology (General): Genetics6
Medicine6
Science: Biology (General): Cytology5
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy3
Medicine: Internal medicine3
Medicine: Internal medicine: Infectious and parasitic diseases2
Science: Biology (General)2
Science2
Science: Science (General)2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system2
Science: Microbiology1
Medicine: Medicine (General): Medical technology1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs1
The category Medicine: Medicine (General) 32 is the most frequently represented among the references in this article. It primarily includes studies from The Lancet Oncology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Research progress in nano-drug delivery systems based on the characteristics of the liver cancer microenvironment Biomedicine & Pharmacotherapy
  • Medicine: Medicine (General)
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2 2024
Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma International Immunopharmacology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2 2024
SiRNA-HIF-1α delivered by attenuated Salmonella enhances the efficacy of Lenvatinib against hepatocellular carcinoma International Immunopharmacology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2024
Response Evaluation Using Contrast-Enhanced Ultrasound for Unresectable Advanced Hepatocellular Carcinoma Treated With Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy Ultrasound in Medicine & Biology
  • Science: Physics: Acoustics. Sound
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
 2024
Macrophage-hitchhiked arsenic/AB bionic preparations for liver cancer

 Biomaterials Science
  • Technology: Chemical technology: Biotechnology
  • Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials
 2024
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)28
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens24
Medicine: Therapeutics. Pharmacology10
Medicine: Public aspects of medicine: Toxicology. Poisons7
Science: Chemistry5
Science: Biology (General)5
Technology: Chemical technology: Biotechnology4
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy3
Science: Biology (General): Genetics3
Science: Biology (General): Cytology3
Science: Chemistry: Organic chemistry: Biochemistry3
Technology: Mechanical engineering and machinery2
Science: Chemistry: General. Including alchemy2
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology2
Science: Chemistry: Physical and theoretical chemistry1
Science: Physics: Heat: Thermodynamics1
Medicine1
Science1
Science: Science (General)1
Science: Physics: Acoustics. Sound1
Agriculture1
Agriculture: Agriculture (General)1
Technology: Home economics: Nutrition. Foods and food supply1
Science: Chemistry: Organic chemistry1
Science: Chemistry: Analytical chemistry1
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials1
Medicine: Internal medicine1
Medicine: Medicine (General): Medical technology1
Technology: Technology (General): Industrial engineering. Management engineering1
Technology: Chemical technology: Food processing and manufacture1
The category Medicine: Medicine (General) 28 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled <p>Complete Response to the Sequential Treatment with Regorafenib Followed by PD-1 Inhibitor in a Sorafenib-Refractory Hepatocellular Carcinoma Patient</p> and was published in 2020. The most recent citation comes from a 2024 study titled Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy for hepatocellular carcinoma patients with portal vein tumor thrombus. This article reached its peak citation in 2022, with 19 citations. It has been cited in 42 different journals, 35% of which are open access. Among related journals, the Frontiers in Oncology cited this research the most, with 10 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year